【结 构 式】 |
【分子编号】61948 【品名】2-chloro-3-quinolinecarboxylic acid 【CA登记号】 |
【 分 子 式 】C10H6ClNO2 【 分 子 量 】207.61588 【元素组成】C 57.85% H 2.91% Cl 17.08% N 6.75% O 15.41% |
合成路线1
该中间体在本合成路线中的序号:(V)Alkylation of 4-amino-3-nitrophenol (I) with 1-(2-chloroethyl)piperidine (II) provides ether (III). Subsequent nitro group reduction in (III) to afford diamine (IV) is performed by means of zinc powder in AcOH. Coupling of diamine (IV) with 2-chloroquinoline-3-carboxylic acid (V) furnishes amide (VI). Then, intramolecular cyclization of amino amide (VI) with Burgess reagent, followed by hydrolysis in boiling 6 M HCl gives rise to the title benzimidazolyl quinolinone.
【1】 Hungate, R.W.; Fraley, M.E.; Hambaugh, S.R. (Merck & Co., Inc.); Tyrosine kinase inhibitors. JP 2003512353; US 6479512; WO 0128993 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 61945 | 4-amino-3-nitrophenol | C6H6N2O3 | 详情 | 详情 | |
(II) | 10117 | 1-(2-Chloroethyl)piperidine; N-(2-Chloroethyl)piperidine | 1932-03-2 | C7H14ClN | 详情 | 详情 |
(III) | 61946 | 2-nitro-4-[2-(1-piperidinyl)ethoxy]aniline; 2-nitro-4-[2-(1-piperidinyl)ethoxy]phenylamine | C13H19N3O3 | 详情 | 详情 | |
(IV) | 61947 | 2-amino-4-[2-(1-piperidinyl)ethoxy]phenylamine; 4-[2-(1-piperidinyl)ethoxy]-1,2-benzenediamine | C13H21N3O | 详情 | 详情 | |
(V) | 61948 | 2-chloro-3-quinolinecarboxylic acid | C10H6ClNO2 | 详情 | 详情 | |
(VI) | 61949 | N-{2-amino-4-[2-(1-piperidinyl)ethoxy]phenyl}-2-chloro-3-quinolinecarboxamide | C23H25ClN4O2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(I)Treatment of 2-chloroquinoline-3-carboxylic acid (I) with oxalyl chloride affords acid chloride (II), which is subsequently coupled with methyl 3,4-diaminobenzoate (III) to yield amide (IV). Intramolecular cyclization of amino amide (IV) with Burgess reagent in refluxing THF produces the benzimidazole (V). Then, acidic hydrolysis of both methyl ester and chloroquinoline functions of (V) gives rise to the carboxylic acid (VI). Coupling of (VI) with N-Boc-piperazine (VII) furnishes amide (VIII). The N-Boc protecting group of (VIII) is finally removed by treatment with trifluoroacetic acid in CH2Cl2.
【1】 Hungate, R.W.; Fraley, M.E.; Hambaugh, S.R. (Merck & Co., Inc.); Tyrosine kinase inhibitors. JP 2003512353; US 6479512; WO 0128993 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 61948 | 2-chloro-3-quinolinecarboxylic acid | C10H6ClNO2 | 详情 | 详情 | |
(II) | 61950 | 2-chloro-3-quinolinecarbonyl chloride | C10H5Cl2NO | 详情 | 详情 | |
(III) | 34921 | 3-cyanobenzoyl chloride | 1711-11-1 | C8H4ClNO | 详情 | 详情 |
(IV) | 61951 | methyl 3-amino-4-{[(2-chloro-3-quinolinyl)carbonyl]amino}benzoate | C18H14ClN3O3 | 详情 | 详情 | |
(V) | 61952 | methyl 2-(2-chloro-3-quinolinyl)-1H-benzimidazole-5-carboxylate | C18H12ClN3O2 | 详情 | 详情 | |
(VI) | 61953 | 2-(2-oxo-1,2-dihydro-3-quinolinyl)-1H-benzimidazole-5-carboxylic acid | C17H11N3O3 | 详情 | 详情 | |
(VII) | 13225 | N-tert-Butoxycarbonyl piperazine; tert-butyl 1-piperazinecarboxylate;tert-butyl piperazine-1-carboxylate | 143238-38-4 | C9H18N2O2 | 详情 | 详情 |
(VIII) | 61954 | tert-butyl 4-{[2-(2-oxo-1,2-dihydro-3-quinolinyl)-1H-benzimidazol-5-yl]carbonyl}-1-piperazinecarboxylate | C26H27N5O4 | 详情 | 详情 |